According to the National Institutes of Health, Idiopathic Pulmonary Fibrosis (IPF) is a rare disease affecting approximately 100,000 patients in the United States. IPF leads to the accumulation of scar tissue in the lungs, progressively making breathing more challenging.  At Leapcure, we’ve engaged with nearly 10,500 IPF patients, gaining invaluable insights from their experiences. Explore… Continue reading Behind the Idiopathic Pulmonary Fibrosis Diagnosis